Evidence map›Paper›PMID 33717003›Full record

ArticleFrontiers in microbiology2021

From the

Solène Geffroy, Marc-Marie Lechat, Mickael Le Gac, Georges-Augustin Rovillon, Dominique Marie, Estelle Bigeard, Florent Malo, Zouher Amzil, Laure Guillou, Amandine M N Caruana

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Insights intoBiology · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Solène GeffroyIFREMER-Phycotoxins Laboratory, Nantes, France.
Marc-Marie LechatIFREMER-Phycotoxins Laboratory, Nantes, France.
Mickael Le GacIFREMER-DYNECO Pelagos, Plouzané, France.
Georges-Augustin RovillonIFREMER-Phycotoxins Laboratory, Nantes, France.
Dominique MarieSorbonne Université, CNRS, UMR 7144 Adaptation et Diversité en Milieu Marin, Station Biologique de Roscoff, Roscoff, France.
Estelle BigeardSorbonne Université, CNRS, UMR 7144 Adaptation et Diversité en Milieu Marin, Station Biologique de Roscoff, Roscoff, France.
Florent MaloIFREMER-Phycotoxins Laboratory, Nantes, France.
Zouher AmzilIFREMER-Phycotoxins Laboratory, Nantes, France.
Laure GuillouSorbonne Université, CNRS, UMR 7144 Adaptation et Diversité en Milieu Marin, Station Biologique de Roscoff, Roscoff, France.
Amandine M N CaruanaIFREMER-Phycotoxins Laboratory, Nantes, France.
Ifremer · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paralytic shellfish poisoning (PSP) is a human foodborne syndrome caused by the consumption of shellfish that accumulate paralytic shellfish toxins (PSTs, saxitoxin group). In PST-producing dinoflagellates such as

Indexed as

Alexandriumcopy number variationexpressionisoformsaxitoxinssxtAsxtA4

Identifiers

PMID33717003
PMCPMC7944994
OpenAlexW3132734183

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.